Representation of the coronavirus, which has had far-reaching impacts on global healthcare, including the emergence of Avascular Necrosis
The healthcare sector has been contending with the fallout of the COVID-19 pandemic, and now a new wave of challenges is emerging. Avascular Necrosis (AVN) of the hip, a condition where bone tissue dies due to inadequate blood supply, is increasingly being reported among post-COVID patients.
Wockhardt Hospitals in Mumbai Central has been addressing this alarming trend. Patients like Mr. Dhananjay Vasant Wagaskar and Ms. Ragini Yadav, despite differing histories of COVID-19 and steroid usage, both developed AVN. MRI scans revealed the diagnosis in both cases.
Dr. Mudit Khanna, a leading Orthopaedic & Joint Replacement Surgeon at Wockhardt Hospitals, underlined the significance of early diagnosis via MRI scans, as AVN can go undetected in its initial stages through X-Rays.
When AVN is diagnosed late, Total Hip Replacement Surgery becomes a necessary course of action. This surgery has witnessed tremendous advancements, making it highly successful and beneficial even for younger patients. The surgery replaces the diseased hip joint with an artificial joint composed of metal, plastic, or ceramic. Dr. Khanna highlighted that improvements in implant materials and surgical techniques contribute significantly to the surgery’s success.
Wockhardt Hospitals’ innovative approach to handling AVN in post-COVID patients exemplifies the ongoing commitment to tackling the unforeseen challenges of this pandemic. Through early diagnosis and cutting-edge treatment, they are ensuring that patients can reclaim their mobility and quality of life.
